{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:28:58Z","timestamp":1779935338768,"version":"3.53.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.clnesp.2025.01.053","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T18:34:04Z","timestamp":1738348444000},"page":"372-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The relationship between serum Omega-6 fatty acids and cardiovascular disease mortality: A competing risks and multivariate Mendelian randomization analysis"],"prefix":"10.1016","volume":"66","author":[{"given":"Huimin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8259-0194","authenticated-orcid":false,"given":"Fangkai","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2025.01.053_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","article-title":"Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study","volume":"395","author":"Yusuf","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clnesp.2025.01.053_bib2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Global Cardiovascular Risk","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnesp.2025.01.053_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101165","article-title":"Polyunsaturated fatty acids and fatty acid-derived lipid mediators: recent advances in the understanding of their biosynthesis, structures, and functions","volume":"86","author":"Dyall","year":"2022","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.clnesp.2025.01.053_bib4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S2213-8587(20)30148-0","article-title":"Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases","volume":"8","author":"Schulze","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clnesp.2025.01.053_bib5","doi-asserted-by":"crossref","first-page":"988","DOI":"10.5851\/kosfa.2024.e65","article-title":"omega-6 and omega-3 polyunsaturated fatty acids: inflammation, obesity and foods of animal resources","volume":"44","author":"Jeong","year":"2024","journal-title":"Food Sci Anim Resour"},{"key":"10.1016\/j.clnesp.2025.01.053_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/nu15143129","article-title":"Linoleic acid: a narrative review of the effects of increased intake in the standard American diet and associations with chronic disease","volume":"15","author":"Mercola","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2025.01.053_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136965","article-title":"Effects of dietary n-3 and n-6 polyunsaturated fatty acids in inflammation and cancerogenesis","volume":"22","author":"Liput","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clnesp.2025.01.053_bib8","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/CIRCULATIONAHA.108.191627","volume":"119","author":"Harris","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.clnesp.2025.01.053_bib9","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/CIRCULATIONAHA.118.038908","article-title":"Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality","volume":"139","author":"Marklund","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.clnesp.2025.01.053_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108838","article-title":"Polyunsaturated fatty acids: conversion to lipid mediators, roles in inflammatory diseases and dietary sources","volume":"24","author":"Harwood","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clnesp.2025.01.053_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/nu13072421","article-title":"Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health: an update for 2021","volume":"13","author":"Djuricic","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2025.01.053_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12937-017-0254-5","article-title":"The effect of replacing saturated fat with mostly n-6 polyunsaturated fat on coronary heart disease: a meta-analysis of randomised controlled trials","volume":"16","author":"Hamley","year":"2017","journal-title":"Nutr J"},{"key":"10.1016\/j.clnesp.2025.01.053_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"10.1016\/j.clnesp.2025.01.053_bib14","unstructured":"National Center for Health Statistics. National health and nutrition examination survey. (Accessed September 20, 2024, at https:\/\/www.cdc.gov\/nchs\/nhanes\/index.htm.)."},{"key":"10.1016\/j.clnesp.2025.01.053_bib15","unstructured":"National Center for Environmental Health. Laboratory method of serum fatty acids in NHANES 2013-2014. (Accessed September 20, 2023, at https:\/\/wwwn.cdc.gov\/Nchs\/Nhanes\/2013&ndash;2014\/FAS_H.htm.)."},{"key":"10.1016\/j.clnesp.2025.01.053_bib16","unstructured":"Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey: NHANES survey methods and analytic guidelines. (Accessed September 20, 2024, at https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/analyticguidelines.aspx.)."},{"key":"10.1016\/j.clnesp.2025.01.053_bib17","unstructured":"National Center for Health Statistics. National Death Index. (Accessed September 20, 2024, at https:\/\/ftp.cdc.gov\/pub\/Health_Statistics\/NCHS\/datalinkage\/linked_mortality\/.)."},{"key":"10.1016\/j.clnesp.2025.01.053_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/ije\/dyr233","article-title":"Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease","volume":"41","author":"Relton","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.clnesp.2025.01.053_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/aje\/kwu283","article-title":"Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects","volume":"181","author":"Burgess","year":"2015","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clnesp.2025.01.053_bib20","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clnesp.2025.01.053_bib21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12944-019-1120-6","article-title":"Fatty acids, epigenetic mechanisms and chronic diseases: a systematic review","volume":"18","author":"Gonzalez-Becerra","year":"2019","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.clnesp.2025.01.053_bib22","article-title":"Omega-6 fats for the primary and secondary prevention of cardiovascular disease","volume":"7","author":"Hooper","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clnesp.2025.01.053_bib23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.atherosclerosis.2013.11.048","article-title":"Omega-6 and omega-3 polyunsaturated fatty acid levels are reduced in whole blood of Italian patients with a recent myocardial infarction: the AGE-IM study","volume":"232","author":"Marangoni","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clnesp.2025.01.053_bib24","first-page":"778","article-title":"Health burden of unbalanced fatty acids intake from 1990 to 2019: a global analysis","volume":"4","author":"Hu","year":"2023","journal-title":"M\u00e9dica Sur"},{"key":"10.1016\/j.clnesp.2025.01.053_bib25","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/CIRCULATIONAHA.114.011590","article-title":"Circulating omega-6 polyunsaturated fatty acids and total and cause-specific mortality: the Cardiovascular Health Study","volume":"130","author":"Wu","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.clnesp.2025.01.053_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/ajcn\/nqx063","article-title":"Serum n-6 polyunsaturated fatty acids and risk of death: the kuopio ischaemic heart disease risk factor study","volume":"107","author":"Virtanen","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clnesp.2025.01.053_bib27","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00394-021-02780-0","article-title":"Serum n-6 polyunsaturated fatty acids and risk of atrial fibrillation: the kuopio ischaemic heart disease risk factor study","volume":"61","author":"Tajik","year":"2022","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clnesp.2025.01.053_bib28","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1039\/D3FO02522E","article-title":"Effects of omega-3, omega-6, and total dietary polyunsaturated fatty acid supplementation in patients with atherosclerotic cardiovascular disease: a systematic review and meta-analysis","volume":"15","author":"Luo","year":"2024","journal-title":"Food Funct"},{"key":"10.1016\/j.clnesp.2025.01.053_bib29","first-page":"466","article-title":"Omega-6 fatty acids and the risk of cardiovascular disease: insights from a systematic review and meta-analysis of randomized controlled trials and a Mendelian randomization study","volume":"18","author":"Mazidi","year":"2022","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.clnesp.2025.01.053_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.plefa.2018.03.004","article-title":"Omega-6 fatty acids and inflammation","volume":"132","author":"Innes","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.clnesp.2025.01.053_bib31","article-title":"Associations of omega-3, omega-6 polyunsaturated fatty acids intake and omega-6: omega-3 ratio with systemic immune and inflammatory biomarkers: NHANES 1999-2020","volume":"11","author":"Li","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.clnesp.2025.01.053_bib32","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1182\/bloodadvances.2020002493","article-title":"Omega-6 DPA and its 12-lipoxygenase-oxidized lipids regulate platelet reactivity in a nongenomic PPARalpha-dependent manner","volume":"4","author":"Yeung","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.clnesp.2025.01.053_bib33","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/advances\/nmy038","article-title":"omega-6 polyunsaturated fatty acids and cardiometabolic health: current evidence, controversies, and research gaps","volume":"9","author":"Maki","year":"2018","journal-title":"Adv Nutr"},{"key":"10.1016\/j.clnesp.2025.01.053_bib34","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.4049\/jimmunol.1801653","article-title":"Anti-inflammatory and proresolving effects of the omega-6 polyunsaturated fatty acid adrenic acid","volume":"205","author":"Brouwers","year":"2020","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.clnesp.2025.01.053_bib35","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/ATVBAHA.116.308050","article-title":"12(S)-HETrE, a 12-lipoxygenase oxylipin of dihomo-gamma-linolenic acid, inhibits thrombosis via galphas signaling in platelets","volume":"36","author":"Yeung","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clnesp.2025.01.053_bib36","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.cmet.2021.08.014","article-title":"Pharmacological inhibition of arachidonate 12-lipoxygenase ameliorates myocardial ischemia-reperfusion injury in multiple species","volume":"33","author":"Zhang","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.clnesp.2025.01.053_bib37","doi-asserted-by":"crossref","first-page":"H953","DOI":"10.1152\/ajpheart.00684.2021","article-title":"Metabolic transformation of fat in obesity determines the inflammation resolving capacity of splenocardiac and cardiorenal networks in heart failure","volume":"322","author":"Halade","year":"2022","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.clnesp.2025.01.053_bib38","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/cvr\/cvab003","article-title":"The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis","volume":"117","author":"Badimon","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.clnesp.2025.01.053_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2023.109331","article-title":"High omega-6\/omega-3 fatty acid and oxylipin ratio in plasma is linked to an adverse cardiometabolic profile in middle-aged adults","volume":"117","author":"Jurado-Fasoli","year":"2023","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1016\/j.clnesp.2025.01.053_bib40","doi-asserted-by":"crossref","first-page":"H160","DOI":"10.1152\/ajpheart.00297.2017","article-title":"Excess omega-6 fatty acids influx in aging drives metabolic dysregulation, electrocardiographic alterations, and low-grade chronic inflammation","volume":"314","author":"Kain","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.clnesp.2025.01.053_bib41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.numecd.2019.09.013","article-title":"Exploring the causal pathway from omega-6 levels to coronary heart disease: a network Mendelian randomization study","volume":"30","author":"Liao","year":"2020","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.clnesp.2025.01.053_bib42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11745-014-3915-6","article-title":"Hypercholesterolemia increases plasma saturated and n-6 fatty acids altering prostaglandin homeostasis and promotes endothelial dysfunction in rabbits","volume":"49","author":"Medina","year":"2014","journal-title":"Lipids"},{"key":"10.1016\/j.clnesp.2025.01.053_bib43","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2011.04.004","article-title":"Relationships among the serum omega fatty acid levels, serum C-reactive protein levels and arterial stiffness\/wave reflection in Japanese men","volume":"217","author":"Tomiyama","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clnesp.2025.01.053_bib44","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/nu8030128","article-title":"An increase in the omega-6\/omega-3 fatty acid ratio increases the risk for obesity","volume":"8","author":"Simopoulos","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2025.01.053_bib45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/aje\/kwr504","article-title":"Serum omega-6 polyunsaturated fatty acids and the metabolic syndrome: a longitudinal population-based cohort study","volume":"176","author":"Vanhala","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.clnesp.2025.01.053_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11123320","article-title":"Altered red blood cell fatty acid and serum adipokine profiles in subjects with obesity","volume":"11","author":"Leniz","year":"2023","journal-title":"Biomedicines"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T17:12:26Z","timestamp":1741972346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725000531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":46,"alternative-id":["S2405457725000531"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.01.053","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between serum Omega-6 fatty acids and cardiovascular disease mortality: A competing risks and multivariate Mendelian randomization analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.01.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}